Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Equal-Weight on Stitch Fix, Lowers Price Target to $37

Barclays analyst Ross Sandler maintains Stitch Fix (NASDAQ:SFIX) with a Equal-Weight and lowers the price target from $59 to $37.

byvishwanath@benzinga.com

September 22, 2021

1 minute read

Barclays analyst Ross Sandler maintains Stitch Fix (NASDAQ:SFIX) with a Equal-Weight and lowers the price target from $59 to $37.

BMO Capital Maintains Outperform on STEP Energy Services, Raises Price Target to C$4

By Benzinga Newsdesk

April 1, 6:54 AM

BMO Capital maintains STEP Energy Services (TSX:STEP) with a Outperform and raises the price target from C$2.5 to C$4.

TSX:STEP

ITT Acquires Clippard Cylinder Product Line For Undisclosed Sum

By Akanksha Bakshi

August 10, 1:13 PM

ITT Inc. (NYSE:ITT) has acquired Clippard Instrument Laboratories’ product lines of durable, low maintenance, and cost-competitive interchangeable pneumatic cylinders. Deal terms…

ITT

Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $37

By Benzinga Newsdesk

March 10, 10:52 AM

Cantor Fitzgerald analyst Charles Duncan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and raises the price target from $32 to $37.

ACAD